Literature DB >> 16760387

Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.

Christian Sinzger1, Kathrin Eberhardt, Yolaine Cavignac, Christof Weinstock, Tobias Kessler, Gerhard Jahn, Jean-Luc Davignon.   

Abstract

The contribution of CD4(+) T cells to control of human cytomegalovirus (HCMV) has been shown and infected tissue macrophages might contribute to this response by antigen presentation. As shown previously, CD4(+) T cells recognize HCMV immediate-early antigen IE1 on glioblastoma cells manipulated to express MHC class II molecules. Here, the possible interference of virus-induced MHC class II downmodulation with the presentation of IE1 by natural target cells was analysed. The capacity of IE1-specific CD4(+) T-cell clones to recognize HCMV-infected monocyte-derived macrophages was tested. Various HCMV strains were used to achieve efficient infection of macrophages. Activation of CD4(+) T cells by infected macrophages was evaluated at different time points after infection. Endothelial-cell-adapted HCMV strains efficiently infected cultured human macrophages. However, the immediate-early and early phases of replication were prolonged. Infected cells entered the late replication phase only after 3 days of infection, which was associated with downmodulation of MHC class II molecules at the surface of infected cells. Strong stimulation of IE1-specific CD4(+) T cells resulted from endogenous de novo antigen production and presentation by infected macrophages during the first 3 days of virus replication, despite MHC class II downmodulation in the late replication phase. Therefore, infected macrophages are assumed to contribute to the antiviral immune response in infected organs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760387     DOI: 10.1099/vir.0.81595-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Authors:  Carina Bayer; Stefania Varani; Li Wang; Paul Walther; Shaoxia Zhou; Sarah Straschewski; Max Bachem; Cecilia Söderberg-Naucler; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection.

Authors:  Andrea Schuessler; Kerstin Laib Sampaio; Laura Scrivano; Christian Sinzger
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Mutational mapping of pUL131A of human cytomegalovirus emphasizes its central role for endothelial cell tropism.

Authors:  Andrea Schuessler; Kerstin Laib Sampaio; Sarah Straschewski; Christian Sinzger
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

4.  Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.

Authors:  Zeguang Wu; Ruifang Qin; Li Wang; Matteo Bosso; Myriam Scherer; Thomas Stamminger; Dominik Hotter; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

5.  Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV.

Authors:  Gretchen L Bentz; Marta Jarquin-Pardo; Gary Chan; M Shane Smith; Christian Sinzger; Andrew D Yurochko
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.

Authors:  Nicolas Lützner; Hubert Kalbacher
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

7.  Charge cluster-to-alanine scanning of UL128 for fine tuning of the endothelial cell tropism of human cytomegalovirus.

Authors:  Andrea Schuessler; Kerstin Laib Sampaio; Christian Sinzger
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.

Authors:  Elisabeth A Pitt; Pranay Dogra; Ravi S Patel; Angela Williams; Jonathan S Wall; Tim E Sparer
Journal:  Antiviral Res       Date:  2016-09-25       Impact factor: 5.970

9.  Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.

Authors:  Giada Frascaroli; Stefania Varani; Nina Blankenhorn; Robert Pretsch; Michael Bacher; Lin Leng; Richard Bucala; Maria Paola Landini; Thomas Mertens
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 10.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.